SCHEMBL11980977

SCHEMBL11980977

COC(=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
CA14 Q9ULX7 2/20 0.39
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
ZDHHC7 Q9NXF8 1/20 0.32
TSHR P16473 2/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
LTA4H P09960 1/20 0.31
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15541937 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL6669595 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL31276635 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL1846267 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL18383650 0.94 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL29020573 0.92 SMN1; SMN2 (0.40) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL17338688 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL6666971 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL31324735 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL15528782 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501478-B2 Trehalose click polymers for delivery of biologically active molecules UNIVERSITY OF CINCINNATI (US) 2013-08-06 US disclosed
US-8372966-B2 Oligonucleotide decoys and methods of use UNIVERSITY OF CINCINNATI (US) 2013-02-12 US disclosed
US-8372966-B2 Oligonucleotide decoys and methods of use UNIVERSITY OF CINCINNATI (US) 2013-02-12 US disclosed
US-20120270927-A1 Polyamides For Nucleic Acid Delivery UNIVERSITY OF CINCINNATI 2012-10-25 US disclosed
US-8236280-B2 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2012-08-07 US disclosed
US-8034619-B2 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2011-10-11 US disclosed
US-8034619-B2 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2011-10-11 US disclosed
US-20110183417-A1 POLYAMIDES FOR NUCLEIC ACID DELIVERY UNIVERSITY OF CINCINNATI 2011-07-28 US disclosed
US-7927873-B2 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2011-04-19 US disclosed
US-7927873-B2 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2011-04-19 US disclosed
US-20090203131-A1 Polyamides for nucleic acid delivery UNIVERSITY OF CINCINNATI (US) 2009-08-13 US disclosed
US-20090124534-A1 Trehalose Click Polymers for Delivery of Biologically Active Molecules UNIVERSITY OF CINCINNATI (US) 2009-05-14 US disclosed
US-20090105115-A1 POLYAMIDES FOR NUCLEIC ACID DELIVERY UNIVERSITY OF CINCINNATI 2009-04-23 US disclosed
US-20090105115-A1 POLYAMIDES FOR NUCLEIC ACID DELIVERY UNIVERSITY OF CINCINNATI 2009-04-23 US disclosed
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE UNIVERSITY OF CINCINNATI 2009-04-16 US disclosed
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE UNIVERSITY OF CINCINNATI 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105115-A1 POLYAMIDES FOR NUCLEIC ACID DELIVERY TLR3, TLR9, TLR6 SMN1; SMN2 1838/4885CA14 221/4885ALDH1A1 3978/4885
US-20090124534-A1 Trehalose Click Polymers for Delivery of Biologically Active Molecules TREH, TK1, DDOST SMN1; SMN2 1855/4885CA14 1240/4885ALDH1A1 3444/4885
US-20120270927-A1 Polyamides For Nucleic Acid Delivery TLR3, TLR9, DCLRE1A SMN1; SMN2 1594/4885CA14 383/4885ALDH1A1 4598/4885
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE NFKB2, IKBKB, NFKBIA SMN1; SMN2 355/4885CA14 3846/4885ALDH1A1 2564/4885
US-20090203131-A1 Polyamides for nucleic acid delivery POLN, CTDSP1, MED12 SMN1; SMN2 1334/4885CA14 762/4885ALDH1A1 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.